Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Botulinum Toxin and Glycopyrrolate Combination Therapy for Hailey-Hailey Disease.

Cutis·2023
Same author

Hand Grip Strength Vs. Locomotor Efficiency in Sitting Volleyball Players.

Journal of human kinetics·2022
Same author

Durable remissions of guttate psoriasis following short courses of IL-17 inhibitors.

International journal of dermatology·2021
Same author

Immunoglobulin G Subclass-Specific Glycosylation Changes in Primary Epithelial Ovarian Cancer.

Frontiers in immunology·2020
Same author

Dupilumab as a novel therapy for bullous pemphigoid: A multicenter case series.

Journal of the American Academy of Dermatology·2020
Same author

Systemic sclerosis - multidisciplinary disease: clinical features and treatment.

Reumatologia·2019

Related Experiment Video

Updated: Mar 13, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

11.0K

Paraneoplastic pemphigus: a short review.

Marta Wieczorek1, Annette Czernik2

  • 1Clinical Department of Dermatology, Central Clinical Hospital of the Ministry of the Interior and Administration, Warsaw, Poland.

Clinical, Cosmetic and Investigational Dermatology
|October 13, 2016
PubMed
Summary

Paraneoplastic pemphigus (PNP) is a rare, severe autoimmune blistering disease linked to cancer. Early diagnosis and treatment are crucial for managing this condition and improving patient outcomes.

Keywords:
direct and indirect immunofluorescencemucositisparaneoplastic pemphigusrituximab

More Related Videos

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
05:05

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Published on: June 17, 2025

1.4K
Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.8K

Related Experiment Videos

Last Updated: Mar 13, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

11.0K
Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
05:05

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Published on: June 17, 2025

1.4K
Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.8K

Area of Science:

  • Autoimmune diseases
  • Dermatology
  • Oncology

Background:

  • Paraneoplastic pemphigus (PNP) is a rare, life-threatening autoimmune blistering disease associated with an underlying malignancy.
  • First described in 1990, PNP affects multiple organ systems, presenting with diverse lesions including severe oral mucosal lesions, skin eruptions, and pulmonary involvement.

Approach:

  • Diagnosis involves identifying systemic complications, skin biopsies for histopathology and immunofluorescence, and serum immunological studies to detect autoantibodies.
  • Key autoantibodies target antigens like desmoplakin I, envoplakin, and periplakin.

Key Points:

  • PNP exhibits at least five clinical variants and variable histological findings.
  • Unlike other pemphigus forms, PNP can affect the gastrointestinal and respiratory tracts.
  • Early and consistent finding is severe stomatitis.

Conclusions:

  • Treatment is challenging; surgical excision of benign neoplasms offers the best outcomes.
  • High-dose corticosteroids with steroid-sparing agents are first-line treatments; rituximab and IVIg are used for treatment failures.
  • Prognosis is generally poor due to tumor progression and infectious complications from immunosuppression, which is the leading cause of death.